Invasive Breast Cancer
1 competing product in clinical development for Invasive Breast Cancer.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Trastuzumab deruxtecan + Durvalumab | Daiichi Sankyo | Phase 2 | Recruiting | 42 |
1 competing product in clinical development for Invasive Breast Cancer.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Trastuzumab deruxtecan + Durvalumab | Daiichi Sankyo | Phase 2 | Recruiting | 42 |